Screener
Amylyx Pharmaceuticals, Inc. AMLX Interest Income
Interest Income at other companies
Other financials
Where this comes from
Reported directly by Amylyx Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InvestmentIncomeInterest.
The source filing: Amylyx Pharmaceuticals, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 7:04 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-336682
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Total operating expenses | 45,693 | 42,857 | 89,472 | 80,660 |
| Loss from operations | (45,693) | (42,857) | (89,472) | (80,660) |
| Other income, net: | ||||
| Interest income | 2,323 | 1,960 | 4,893 | 4,191 |
| Other expense, net | (53) | (546) | (128) | (881) |
| Total other income, net | 2,270 | 1,414 | 4,765 | 3,310 |
| Net loss | $(43,423) | $(41,443) | $(84,707) | $(77,350) |
| Net loss per share — basic and diluted | $(0.39) | $(0.46) | $(0.76) | $(0.88) |
Item 1. Financial Statements.
FAQ
- What is Amylyx Pharmaceuticals, Inc.'s interest income?
- Amylyx Pharmaceuticals, Inc. (AMLX) reported interest income of $2.32M in Q2 2026.
- How has Amylyx Pharmaceuticals, Inc.'s interest income changed year-over-year?
- Amylyx Pharmaceuticals, Inc.'s interest income increased by 18.5% year-over-year, from $1.96M to $2.32M.
- What is the long-term trend for Amylyx Pharmaceuticals, Inc.'s interest income?
- Over 4 years (2021 to 2025), Amylyx Pharmaceuticals, Inc.'s interest income has grown at a 300.9% compound annual growth rate (CAGR), from $36K to $9.3M.
- What does interest income mean?
- Income earned from interest-bearing assets including cash deposits, money market funds, treasury securities, corporate bonds, and customer financing receivables.
Ask your AI about Amylyx Pharmaceuticals, Inc.'s interest income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude